Virtus LifeSci Net Asset

Virtus LifeSci Biotech Products ETF -- USA Etf  

USD 41.85  1.27  2.95%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

Net Asset Analysis

Net Asset is current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assest is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Virtus LifeSci 
Net Asset 
Current Market Value 
Current Liabilities 
37.67 M

About Net Asset

Net Asset is the value used in calulating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formullay that uses closing prices of all positions in the fund's portfolio.
Compare to competition
Based on recorded statements Virtus LifeSci Biotech Products ETF has Net Asset of 37.67 M. This is much higher than that of the BioShares family, and significantly higher than that of Sector category, The Net Asset for all etfs is over 1000% lower than the firm.

Peer Comparison

Virtus LifeSci Net Asset Comparison
  Net Asset 
      Virtus LifeSci Comparables 
Virtus LifeSci is currently under evaluation in net asset as compared to similar ETFs.

Did you try this?

Run CEO Directory Now

CEO Directory

Screen CEOs from public companies around the world
Hide  View All  NextLaunch CEO Directory

Asset Allocation

Fund Instrument Allocation for Virtus LifeSci
The fund invests 100.0% of asset under management in tradable equity instruments, with the rest of investments concentrated in .
      Instrument Type 

Fundamental Indicators

Current Virtus LifeSci financial ratios